Visit RTsafe at booth #9.

RTsafe announces PseudoPatient™ Prime, a new head phantom that offers comprehensive dosimetry in a true-to-life human anatomy for End-to-End quality assurance (QA) of challenging radiotherapy applications such as cranial stereotactic radiosurgery (SRS).

RTsafe announces that it has signed DosimETrICA as its exclusive distributor for Italy.

RTsafe announces that it has signed Oncology Imaging Systems as its exclusive distributor for the United Kingdom.

Meet us in Milan to learn about our end-to-end solutions for quality assurance in radiation oncology. Booth # 4400.

RTsafe and Elekta today announced that they have entered into a partnership agreement under which Elekta will provide RTsafe’s innovative 3D printed PseudoPatient™ phantoms combined with 3D remote dosimetry services, to its customers.

RTsafe announces that it has signed Abex Medical System as its exclusive distributor for Malaysia, Brunei, Vietnam, Myanmar, and Singapore.

The Forbes article discusses RTsafe's growth and how the company enhances the safety and efficiency in radiotherapy for brain cancer.

As part of the growing regional cooperation between Israel, Cyprus and Greece and acknowledging the great importance of cooperation in the field of innovation; high technology & entrepreneurship, RTsafe recently participated at a seminar in Israel.

Hygeia Hospital turned to RTsafe for its unique approach to quality assurance which significantly enhances the safety & efficiency of radiotherapy for cancer, especially when advanced radiotherapy applications, such as stereotactic radiosurgery, are used.